Renaissance Technologies’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,497
| Closed | -$41.2K | – | 4000 |
|
|
2024
Q3 | $41.2K | Buy |
20,497
+5,720
| +39% | +$11.3K | ﹤0.01% | 3365 |
|
|
2024
Q2 | $24.5K | Buy |
14,777
+1,579
| +12% | +$4.14K | ﹤0.01% | 3364 |
|
|
2024
Q1 | $80K | Buy |
13,198
+1,701
| +15% | +$11.1K | ﹤0.01% | 3409 |
|
|
2023
Q4 | $81K | Buy |
11,497
+5,277
| +85% | +$41K | ﹤0.01% | 3358 |
|
|
2023
Q3 | $54K | Buy |
6,220
+2,200
| +55% | +$20.6K | ﹤0.01% | 3391 |
|
|
2023
Q2 | $47K | Buy |
4,020
+716
| +22% | +$10.3K | ﹤0.01% | 3629 |
|
|
2023
Q1 | $57K | Buy |
3,304
+418
| +14% | +$9.06K | ﹤0.01% | 3634 |
|
|
2022
Q4 | $76K | Buy |
+2,886
| New | +$137K | ﹤0.01% | 3700 |
|
|
2021
Q4 | – | Sell |
-3,480
| Closed | -$672K | – | 4293 |
|
|
2021
Q3 | $672K | Sell |
3,480
-3,828
| -52% | -$813K | ﹤0.01% | 2756 |
|
|
2021
Q2 | $1.76M | Buy |
7,308
+4,720
| +182% | +$1.29M | ﹤0.01% | 2344 |
|
|
2021
Q1 | $878K | Buy |
2,588
+1,188
| +85% | +$483K | ﹤0.01% | 2662 |
|
|
2020
Q4 | $501K | Sell |
1,400
-2,904
| -67% | -$1.12M | ﹤0.01% | 2815 |
|
|
2020
Q3 | $1.99M | Sell |
4,304
-1,103
| -20% | -$311K | ﹤0.01% | 2142 |
|
|
2020
Q2 | $779K | Buy |
+5,407
| New | +$684K | ﹤0.01% | 2676 |
|
Other funds holding TFFP
Renaissance Technologies's TFFP Position: Q4 2024 in Review
Renaissance Technologies sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 20,497 shares — an estimated $41.2K sold.
Renaissance Technologies first reported a position in TFFP in Q2 2020 and held it in 14 quarters. The position peaked at $1.99M in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Renaissance Technologies reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Renaissance Technologies sold 20,497 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $41.2K.
- Renaissance Technologies first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
- Renaissance Technologies's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.99M in Q3 2020.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.